Cite
HARVARD Citation
Burmester, G. et al. (2007). Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial. Annals of the rheumatic diseases. 66 (6), pp. 732-739. [Online].